Home›Companies›Biotech & Pharma›Macrotope

Macrotope, Inc.

Updated Oct 29, 2026·Latest SEC filing May 30, 2025·Suggest an edit

About Macrotope

Macrotope is a private company based in Princeton, New Jersey. It has reported $900,000 raised in three offerings on Form D since June 2022. Its chief executive is Stephen Anderson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 27, 2025May 30, 2025$400,000of $1.0M target1$400KDebtRule 506(b)Form D ↗
Aug 14, 2023Aug 18, 2023$300,000of $750K target1$300KDebtRule 506(b)Form D ↗
May 20, 2022Jun 3, 2022$200,000of $750K target1$200KDebtRule 506(b)Form D ↗
Total, three offerings$900,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Macrotope's Form D filed May 30, 2025.

EC
Elliot Camptbell
Executive officer and director
SA
Stephen Anderson
Chief Executive Officer and director

Earlier filings also listed Elliot Campbell (executive officer and director, last listed Aug 2023).

Sources

  1. SECMacrotope, Inc. filing history